Clinical utility of rapid disk-based combination susceptibility testing in carbapenem-resistant Acinetobacter baumannii infection
Frontiers in Cellular and Infection Microbiology · 18.11.2026 · 16
DOI: 10.3389/fcimb.2026.1999081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.11.2026. Verfasst von Huijuan Yao und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The clinical utility of in vitro combination susceptibility testing for carbapenem-resistant Acinetobacter baumannii (CRAB) infection remains uncertain. We evaluated the clinical utility of a rapid disk-based combination susceptibility approach.
Methods
This retrospective single-center study included patients with CRAB infection undergoing disk-based combination susceptibility testing between September 2024 and June 2026. Disk approximation results were compared with checkerboard testing in a selected validation subset. The primary outcome was 30-day all-cause mortality, with day-15 treatment effectiveness as the secondary outcome.
Results
Seventy-six patients were included. In nine selected isolates, 90 paired isolate–combination assessments showed complete categorical concordance between disk approximation and checkerboard testing after synergy and additivity were grouped as favorable interactions. In day-3 landmark Cox analysis, early favorable-interaction therapy was associated with a lower hazard of 30-day mortality in both univariable and multivariable analyses (adjusted hazard ratio 0.25, 95% CI 0.10–0.63; P = 0.003). Early appropriate therapy showed a protective trend but was not significant after adjustment (adjusted hazard ratio 0.45, 95% CI 0.17–1.15; P = 0.094). Day-15 treatment effectiveness was achieved in 44/76 patients (57.9%). Early favorable-interaction therapy was independently associated with higher odds of day-15 effectiveness (adjusted odds ratio 6.36, 95% CI 2.00–22.99; P = 0.003).
Conclusions
The disk-based approach showed encouraging agreement with checkerboard testing and can be integrated into routine susceptibility workflows. Early favorable-interaction therapy was associated with lower mortality and better treatment response, supporting the potential clinical utility of rapid disk-based combination susceptibility testing for early treatment optimization in CRAB infection.
Zitieren
APA
Yao, H., Wang, X., Liu, J., Bu, S., Chen, J., & Jiao, Z. (2026). Clinical utility of rapid disk-based combination susceptibility testing in carbapenem-resistant Acinetobacter baumannii infection. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1999081
Vancouver
Yao H, Wang X, Liu J, Bu S, Chen J, Jiao Z. Clinical utility of rapid disk-based combination susceptibility testing in carbapenem-resistant Acinetobacter baumannii infection. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1999081
BibTeX
@article{Yao2026,
author = {Yao, Huijuan and Wang, Xinyi and Liu, Jingxian and Bu, Shuhong and Chen, Jihui and Jiao, Zheng},
title = {Clinical utility of rapid disk-based combination susceptibility testing in carbapenem-resistant Acinetobacter baumannii infection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1999081}
}
EUVIMED